Gaurav Kumar Pandey

In 2015, I joined the Lohuizen lab as a Post-doctoral fellow. My current project involves understanding the contribution of tumor suppressor gene, BAP1 in malignant mesotheliomas, delineating its interplay with repressive chromatin modifiers (PcG proteins) and developing combination treatment strategies for BAP1 deficient mesothelioma.

Additionally, I am involved in identifying therapeutic vulnerabilities in aggressive brain tumor- Glioblastoma. Our current focus involves formulating efficient druggable combinations in in vivo models of Glioblastomas.